No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Household & Personal Products
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.
www.reckitt.comNo one on the platform currently holds 3RB.DE.
No tracked institution reports a position in 3RB.DE as of their last filing.
No one on the platform has traded 3RB.DE yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 20.1% | — | — | — | ||
| Rev. Growth % | 0.3% | 0.3% | ||||
| Profit Margin % | 22.4% | 11.9% | 12.9% | |||
| Free Cash Flow Margin % | 12.4% | 13.3% | 15.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $13.4B | -5.9% | $3.44 | $3.12–$3.84 | — | 1 |
| 2027 | $13.7B | +2.4% | $3.69 | $3.34–$4.12 | — | 1 |
| 2028 | $14.2B | +3.4% | $3.94 | $3.58–$4.41 | — | 1 |
| 2029 | $14.7B | +3.8% | $4.24 | $3.85–$4.74 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-29 | $1.65 | $1.17 | -29.1% |
| 2026-03-05 | $2.16 | $2.11 | -2.3% |
| 2025-07-24 | $1.97 | $1.71 | -13.2% |
| 2025-03-06 | $1.94 | $2.36 | +21.6% |
| 2024-07-24 | $1.91 | $1.98 | +3.7% |
| 2024-02-28 | $1.76 | $1.24 | -29.5% |
| 2023-07-26 | $2.07 | $2.10 | +1.4% |
| 2023-03-01 | $1.95 |
| $1.92 |
| -1.5% |
| +0.11% |
| $41.9B |
| — |
| HEN3.DEHenkel AG & Co. KGaA | $73.42 | +0.74% | $30.4B | — |
| HEN3.FHenkel AG & Co. KGaA | $72.78 | -0.30% | $30.2B | — |
Source: Financial Modeling Prep · peers by sector/industry